These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16213718)

  • 1. New metabolically stable fatty acid amide ligands of cannabinoid receptors: Synthesis and receptor affinity studies.
    Urbani P; Cavallo P; Cascio MG; Buonerba M; De Martino G; Di Marzo V; Saturnino C
    Bioorg Med Chem Lett; 2006 Jan; 16(1):138-41. PubMed ID: 16213718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase.
    van der Stelt M; van Kuik JA; Bari M; van Zadelhoff G; Leeflang BR; Veldink GA; Finazzi-Agrò A; Vliegenthart JF; Maccarrone M
    J Med Chem; 2002 Aug; 45(17):3709-20. PubMed ID: 12166944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First "hybrid" ligands of vanilloid TRPV1 and cannabinoid CB2 receptors and non-polyunsaturated fatty acid-derived CB2-selective ligands.
    Appendino G; Cascio MG; Bacchiega S; Moriello AS; Minassi A; Thomas A; Ross R; Pertwee R; De Petrocellis L; Di Marzo V
    FEBS Lett; 2006 Jan; 580(2):568-74. PubMed ID: 16406364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications.
    Lambert DM; Fowler CJ
    J Med Chem; 2005 Aug; 48(16):5059-87. PubMed ID: 16078824
    [No Abstract]   [Full Text] [Related]  

  • 5. N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo.
    Bisogno T; Melck D; Bobrov MYu ; Gretskaya NM; Bezuglov VV; De Petrocellis L; Di Marzo V
    Biochem J; 2000 Nov; 351 Pt 3(Pt 3):817-24. PubMed ID: 11042139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and binding studies of new potent ligands of cannabinoid receptors.
    Brizzi A; Brizzi V; Cascio MG; Bisogno T; Sirianni R; Di Marzo V
    J Med Chem; 2005 Nov; 48(23):7343-50. PubMed ID: 16279794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel selective and metabolically stable inhibitors of anandamide cellular uptake.
    Ortar G; Ligresti A; De Petrocellis L; Morera E; Di Marzo V
    Biochem Pharmacol; 2003 May; 65(9):1473-81. PubMed ID: 12732359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational requirements for endocannabinoid interaction with the cannabinoid receptors, the anandamide transporter and fatty acid amidohydrolase.
    Reggio PH; Traore H
    Chem Phys Lipids; 2000 Nov; 108(1-2):15-35. PubMed ID: 11106780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, binding studies and molecular modeling of novel cannabinoid receptor ligands.
    Osman NA; Mahmoud AH; Allarà M; Niess R; Abouzid KA; Di Marzo V; Abadi AH
    Bioorg Med Chem; 2010 Dec; 18(24):8463-77. PubMed ID: 21074998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors.
    Melck D; Bisogno T; De Petrocellis L; Chuang H; Julius D; Bifulco M; Di Marzo V
    Biochem Biophys Res Commun; 1999 Aug; 262(1):275-84. PubMed ID: 10448105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted stable-isotope dilution GC-MS/MS analysis of the endocannabinoid anandamide and other fatty acid ethanol amides in human plasma.
    Zoerner AA; Gutzki FM; Suchy MT; Beckmann B; Engeli S; Jordan J; Tsikas D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Sep; 877(26):2909-23. PubMed ID: 19414283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and biological evaluation of new endocannabinoid transporter inhibitors.
    López-Rodríguez ML; Viso A; Ortega-Gutiérrez S; Fowler CJ; Tiger G; de Lago E; Fernández-Ruiz J; Ramos JA
    Eur J Med Chem; 2003 Apr; 38(4):403-12. PubMed ID: 12750028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor.
    Deutsch DG; Lin S; Hill WA; Morse KL; Salehani D; Arreaza G; Omeir RL; Makriyannis A
    Biochem Biophys Res Commun; 1997 Feb; 231(1):217-21. PubMed ID: 9070252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modifications of the ethanolamine head in N-palmitoylethanolamine: synthesis and evaluation of new agents interfering with the metabolism of anandamide.
    Vandevoorde S; Jonsson KO; Fowler CJ; Lambert DM
    J Med Chem; 2003 Apr; 46(8):1440-8. PubMed ID: 12672243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and biological evaluation of new inhibitors of the endocannabinoid uptake: comparison with effects on fatty acid amidohydrolase.
    López-Rodríguez ML; Viso A; Ortega-Gutiérrez S; Fowler CJ; Tiger G; de Lago E; Fernández-Ruiz J; Ramos JA
    J Med Chem; 2003 Apr; 46(8):1512-22. PubMed ID: 12672252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel natural and synthetic ligands of the endocannabinoid system.
    Hanus LO; Mechoulam R
    Curr Med Chem; 2010; 17(14):1341-59. PubMed ID: 20166928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulatory lipids in plants: plant fatty acid amides and the human endocannabinoid system.
    Gertsch J
    Planta Med; 2008 May; 74(6):638-50. PubMed ID: 18275004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploration of biologically relevant conformations of anandamide, 2-arachidonylglycerol, and their analogues using conformational memories.
    Barnett-Norris J; Guarnieri F; Hurst DP; Reggio PH
    J Med Chem; 1998 Nov; 41(24):4861-72. PubMed ID: 9822555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From cannabis to cannabinergics: new therapeutic opportunities.
    Goutopoulos A; Makriyannis A
    Pharmacol Ther; 2002 Aug; 95(2):103-17. PubMed ID: 12182958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, cannabinoid receptor activity, and enzymatic stability of reversed amide derivatives of arachidonoyl ethanolamide.
    Parkkari T; Savinainen JR; Raitio KH; Saario SM; Matilainen L; Sirviö T; Laitinen JT; Nevalainen T; Niemi R; Järvinen T
    Bioorg Med Chem; 2006 Aug; 14(15):5252-8. PubMed ID: 16644227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.